Drawing for NUVEL HEALTH

USPTO serial 50054144

NUVEL HEALTH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DAVIS, MARC STEPHEN
Law office
TMO LAW OFFICE 122

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with NUVEL HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yihao Huang

1178 Broadway, 3rd Floor #3103New York, NY 10001United States

Goods and services

ClassDescriptionStatusFirst use
005Vitamin and mineral supplements; Dietary food supplements; Dietary and nutritional supplements; Nutritional supplements; Dietary supplements for human consumption; Nutraceuticals for use as a dietary supplement; Natural dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 16, 2026DOCKASSIGNED TO EXAMINER—
Aug 17, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 17, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 17, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance